Medicare Part D premiums for standalone drug plans are set to jump sharply in 2027, outpacing Advantage plan cost increases ...

Italian nonprofit Fondazione Telethon and US nonprofit Orphan Therapeutics Accelerator are collaborating to bring curative ...

The firm has closed an oversubscribed Series B, fueling two bold TCR-bispecific programs targeting cancer and autoimmune ...

Alethio Therapeutics has closed an oversubscribed $90 million Series A, providing the capital to advance to clinical stage.

Boehringer Ingelheim and Microsoft are partnering to build AI-driven digital patient twins that simulate disease progression ...

Reverse mergers promise fast access to public markets – but DeeDee DeMan warns founders that leadership and governance readiness often lag behind.

AbbVie is paying up front and betting on a Japanese biotech's gut-restricted molecule to tackle inflammatory bowel disease ...

The biotech has raised $25 million to scale its human cell models, targeting industry-standard status as drug discovery ...

Anthropic wants to use AI to address common bottlenecks in clinical trials and says collaborations with B-MS and Enveda – as ...

GSK leader shares tips on how to always keep mature brand speaker programs relevant, credible and compliant over time.

Some have called this announcement a "yellow light" or "backdoor" approval of these gray-market peptides. However, the HHS ...

START and IFO launch a new early-phase cancer trial site in Rome, giving patients access to novel investigational treatments ...